

| Numéro de catalogue | DS856028 |
|---|---|
| Description |
Bimekizumab ELISA Kit (DS856028) — Quantitative sandwich ELISA for Bimekizumab. Sample: Plasma, Serum. Range: 0.31-5 μg/mL. Sensitivity: 0.156 μg/ml.
Highlights
|
| Type d'échantillon | Plasma, Serum |
| Sensibilité | 0.156 μg/ml |
| Plage | 0.31-5 μg/mL |
| Numéro d'accès | Q16552 & Q96PD4 |
| Applications | ELISA |
| Méthode de détection | Colorimetric |
| Type de test | Quantitative |
| Retraitement | 80-120% |
| Expédition | 2-8 ℃ |
| Stabilité et stockage | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| Spécifications | Bimekizumab |
| Noms alternatifs | CDP4940, UCB-4940, UCB4940, 1418205-77-2 |
| Contexte | Bimekizumab is an investigational humanized IgG1 monoclonal antibody in development for the treatment of moderate to severe plaque psoriasis in adults. Bimekizumab is designed to selectively and directly inhibit both IL-17A and IL-17F, two key cytokines driving the inflammatory process in plaque psoriasis. |
| Note | For Research Use Only. |

Standard Curve of Bimekizumab ELISA Kit
Contactez-nous pour les devis personnalisés, les demandes en gros et tout autre problème.
Courrier : [email protected]


+86-027-65523339
Bâtiment C, No. 666, Rue Shendunsi, Wuhan, 430206, Chine
中文
English
한국어
日本語
Español
Français
Русский